Solid-state Conformations of Pharmaceutical Polymorphs in Solution: Validation and Invalidation by NMR?

Abstract

Polymorphism is an important research area in the pharmaceutical industry because it provides understanding of how different crystalline forms of a drug can affect its physical and chemical properties, thereby impacting therapeutic efficacy. While polymorphism is conventionally associated with the solid-state, recent studies have suggested that crystalline polymorphs can retain their conformational memory even when they are dissolved in a solvent. Kumar et al. reported that the polymorphic states of the anticancer drug, (Z)-5-(4-(dimethylamino) benzylidene)-2-(piper- idin-1-yl) thiazol-4(5H)-one (1), retained their distinct molecular conformations of the crystal structure even in the solution phase (Crystal Growth and Design, 2023, 23(1), 580-591). The NMR chemical shift perturbations of polymorphs in solution were utilized to establish the presence of distinct conformations by Kumar et al. However, small molecules in solution-state undergo rapid conformational interconversions due to low potential energy barriers, and this makes the characterization of different conformational polymorphs particularly challenging in solvents. Solid-state and solution-state NMR spectroscopy was employed to elucidate the similarities and differences between the spectra of polymorphs of 1 in the solid and solution phases. Our analysis focusses on the spectral pattern and chemical shift differences (Δ𝛿) between signals of different polymorphs, both in solution and solid phase. Clear structural and chemical shift differences were observed for the crystalline polymorphs by solid-state NMR. In solution, the differences in chemical shifts among the polymorphs are negligible or near the limit of detection, highlighting the importance of caution when interpreting small NMR chemical shift variations as evidence for different polymorphs. The magnitude and origin of the observed 1H chemical shift differences for the polymorphs of 1 are analyzed, and the validated NMR methodology presented herein is expected to be applicable to other conformational polymorphic systems.

Supplementary files

Article information

Article type
Paper
Submitted
25 Nov 2025
Accepted
09 Jan 2026
First published
16 Jan 2026

CrystEngComm, 2026, Accepted Manuscript

Solid-state Conformations of Pharmaceutical Polymorphs in Solution: Validation and Invalidation by NMR?

K. Joshi, S. Sangwan, K. V. J. Jose, V. Agarwal and A. Nangia, CrystEngComm, 2026, Accepted Manuscript , DOI: 10.1039/D5CE01120E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements